The DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
Serum therapy revisited: animal models of infection and development of passive antibody therapy
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical benefit was demonstrated for invasive bacterial infections (Casadevall & Scharff, 1994), for various viral diseases (Janeway, 1945; Hammon et al, 1953), as well as for anti‐fungal therapy (Bugli et al, 2013)”
From mRNA mediates passive vaccination against infectious agents, toxins, and tumors (2017) · cites this paper as Casadevall & Scharff, 1994
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
Köhler, G., & Milstein, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,200
The principles and practice of medicine
(1938) · The American Journal of Surgery · doi:10.1016/s0002-9610(38)91188-2 · Cited by 1,657
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.
LoBuglio, A. F., Wheeler, R. H., Trang, J. M., Haynes, A., Rogers, K., Harvey, E. B., Sun, L., Ghrayeb, J., & Khazaeli, M. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4220 · Cited by 524
Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.
Schroff, R. W., Foon, K. A., Beatty, S. M., Oldham, R. K., & Morgan, A. C. (1985) · PubMed · Cited by 488
THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS
Flexner, S. (1913) · The Journal of Experimental Medicine · doi:10.1084/jem.17.5.553 · Cited by 175
Cooper, G. M., Rosenstein, C., Walter, A. W., & Peizer, L. R. (1932) · The Journal of Experimental Medicine · doi:10.1084/jem.55.4.531 · Cited by 96
SEROLOGICAL RELATIONSHIPS AMONG MENINGOCOCCI
Branham, S. E. (1953) · Bacteriological Reviews · doi:10.1128/br.17.3.175-188.1953 · Cited by 84
In Vitro Antibodies: Strategies for Production and Application
Morrison, S. L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.001323 · Cited by 83
Experimental Meningococcal Infection in Mice
Miller, C. P. (1933) · Science · doi:10.1126/science.78.2024.340 · Cited by 77
A BIOLOGIC CLASSIFICATION OF PNEUMOCOCCI BY MEANS OF IMMUNITY REACTIONS
Dochez, A. R. (1913) · JAMA · doi:10.1001/jama.1913.04350100005003 · Cited by 74
The Serum Treatment of Lobar Pneumonia
Finland, M. (1930) · New England Journal of Medicine · doi:10.1056/nejm193006262022605 · Cited by 71
THE TREATMENT OF LOBAR PNEUMONIA WITH REFINED SPECIFIC ANTIBACTERIAL SERUM
PARK, W. H. (1928) · JAMA · doi:10.1001/jama.1928.02700200001001 · Cited by 66
EXPERIMENTAL CEREBRO-SPINAL MENINGITIS IN MONKEYS
Flexner, S. (1907) · The Journal of Experimental Medicine · doi:10.1084/jem.9.2.142 · Cited by 53
Hemophilus influenzae(Pfeiffer Bacillus) Meningitis and Its Specific Treatment
FOTHERGILL, L. R. D. (1937) · New England Journal of Medicine · doi:10.1056/nejm193704082161401 · Cited by 52
Experimental Meningococcal Infection in the Mouse
Miller, C. P., & Castles, R. (1936) · The Journal of Infectious Diseases · doi:10.1093/infdis/58.3.263 · Cited by 51
THE RELIABILITY OF SPUTUM TYPING AND ITS RELATION TO SERUM THERAPY
Bullowa, J. G. M. (1935) · JAMA · doi:10.1001/jama.1935.02760450032007 · Cited by 47
Combinatorial immunoglobulin libraries in phage λ
Kang, A. S., Burton, D. R., & Lerner, R. A. (1991) · Methods · doi:10.1016/s1046-2023(05)80211-7 · Cited by 41
Virological Studies in Natural Common Colds in Sheffield in 1960
Hobson, D., & Schild, G. C. (1960) · BMJ · doi:10.1136/bmj.2.5210.1414 · Cited by 40
A FURTHER STUDY ON THE BIOLOGIC CLASSIFICATION OF PNEUMOCOCCI
Avery, O. T. (1915) · The Journal of Experimental Medicine · doi:10.1084/jem.22.6.804 · Cited by 39
ANTIPNEUMOCOCCUS RABBIT SERUM AS A THERAPEUTIC AGENT IN LOBAR PNEUMONIA
Horsfall, F. L. (1937) · JAMA · doi:10.1001/jama.1937.02780180007003 · Cited by 37
THE PROTECTIVE ACTION OF TYPE I ANTIPNEUMOCOCCUS SERUM IN MICE
Goodner, K., & Horsfall, F. L. (1935) · The Journal of Experimental Medicine · doi:10.1084/jem.62.3.359 · Cited by 37
Sabin, A. B. (1930) · The Journal of Infectious Diseases · doi:10.1093/infdis/46.6.469 · Cited by 35
PNEUMOCOCCUS TYPE II PNEUMONIA
Cecil, R. L. (1932) · JAMA · doi:10.1001/jama.1932.02730360001001 · Cited by 33
The Units of Protective Antibody in Anti-Pneumococcus Serum and Antibody Solution
Felton, L. D. (1928) · The Journal of Infectious Diseases · doi:10.1093/infdis/43.6.531 · Cited by 33
SERUM TREATMENT OF EPIDEMIC CEREBRO-SPINAL MENINGITIS
Flexner, S., & Jobling, J. W. (1908) · The Journal of Experimental Medicine · doi:10.1084/jem.10.1.141 · Cited by 31
Cecil, R. L., & PLUMMER, N. (1930) · JAMA · doi:10.1001/jama.1930.02720210001001 · Cited by 31
EXPERIMENTAL INTRADERMAL PNEUMOCOCCUS INFECTION IN RABBITS
Goodner, K. (1928) · The Journal of Experimental Medicine · doi:10.1084/jem.48.1.1 · Cited by 30
THE TREATMENT OF LOBAR PNEUMONIA WITH CONCENTRATED ANTIPNEUMOCOCCUS SERUM
Cecil, R. L. (1928) · JAMA · doi:10.1001/jama.1928.02700260001001 · Cited by 30
TREATMENT OF PNEUMONIA BY MEANS OF SPECIFIC SERUMS
Cole, R. (1913) · JAMA · doi:10.1001/jama.1913.04350090031011 · Cited by 30
EXPERIMENTAL CEREBROSPINAL MENINGITIS AND ITS SERUM TREATMENT.
Flexner, S. (1906) · JAMA · doi:10.1001/jama.1906.25210080012002c · Cited by 29
SERUM AND SULPHANILAMIDE IN ACUTE MENINGOCOCCAL MENINGITIS
Banks, H. (1938) · The Lancet · doi:10.1016/s0140-6736(00)87994-5 · Cited by 29
THE PRODUCTION OF ANTIPNEUMOCOCCIC SERUM
Cole, R., & Moore, H. F. (1917) · The Journal of Experimental Medicine · doi:10.1084/jem.26.4.537 · Cited by 28
Versuche zur Serodiagnostik und Serotherapie der epidemischen Genickstarre1)
Jochmann, G. (1906) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1142033 · Cited by 27
THE MECHANISM OF THE CURATIVE ACTION OF ANTIPNEUMOCOCCUS SERUM
Bull, C. G. (1915) · The Journal of Experimental Medicine · doi:10.1084/jem.22.4.457 · Cited by 27
INTRAVENOUS TREATMENT OF MENINGOCOCCIC MENINGITIS WITH MENINGOCOCCUS ANTITOXIN
Hoyne, A. L. (1936) · JAMA · doi:10.1001/jama.1936.02770330008003 · Cited by 26
STUDIES ON EXPERIMENTAL PNEUMONIA
Cecil, R. L., & Blake, F. G. (1920) · The Journal of Experimental Medicine · doi:10.1084/jem.31.6.685 · Cited by 26
THE PRESENCE OF PROTECTIVE SUBSTANCES IN HUMAN SERUM DURING LOBAR PNEUMONIA
Dochez, A. R. (1912) · The Journal of Experimental Medicine · doi:10.1084/jem.16.5.665 · Cited by 25
CLINICAL AND BACTERIOLOGIC STUDY OF ONE THOUSAND CASES OF LOBAR PNEUMONIA
Cecil, R. L., & Larsen, N. P. (1922) · JAMA · doi:10.1001/jama.1922.02640050005003 · Cited by 25
EFFECTS OF VERY EARLY SERUM TREATMENT IN PNEUMOCOCCUS TYPE I PNEUMONIA
Cecil, R. L. (1937) · JAMA · doi:10.1001/jama.1937.02780090001001 · Cited by 24
Finland, M., & Ruegsegger, J. M. (1935) · Journal of Clinical Investigation · doi:10.1172/jci100731 · Cited by 24
FURTHER EXPERIMENTS WITH THE INTRADERMAL PNEUMOCOCCUS INFECTION IN RABBITS
Goodner, K. (1928) · The Journal of Experimental Medicine · doi:10.1084/jem.48.3.413 · Cited by 24
THE MENINGOCOCCUS (NEISSERIA INTRACELLULARIS)
Branham, S. E. (1940) · Bacteriological Reviews · doi:10.1128/br.4.2.59-96.1940 · Cited by 23
Meningococcus Meningitis in Detroit in 1928-1929. I. Epidemiology.
Norton, J. F., & Gordon, J. E. (1930) · Cited by 20
MENINGOCOCCIC MENINGITIS IN CHILDREN
NEAL, J. B. (1935) · JAMA · doi:10.1001/jama.1935.02760340014006 · Cited by 19
Type Specific Antipneumococcus Rabbit Serum
Horsfall, F. L., Goodner, K., & MacLeod, C. M. (1936) · Science · doi:10.1126/science.84.2191.579 · Cited by 18
CONCERNING A SERUM-THERAPY FOR EXPERIMENTAL INFECTION WITH DIPLOCOCCUS INTRACELLULARIS
Flexner, S. (1907) · The Journal of Experimental Medicine · doi:10.1084/jem.9.2.168 · Cited by 16
USE OF ANTIPNEUMOCOCCIC REFINED SERUM IN LOBAR PNEUMONIA
Bullowa, J. G. M. (1928) · JAMA · doi:10.1001/jama.1928.02690440010004 · Cited by 15
CERTAIN ASPECTS OF MOUSE PROTECTION TESTS FOR ANTIBODY IN PNEUMOCOCCUS PNEUMONIA
Lord, F. T., & Persons, E. L. (1931) · The Journal of Experimental Medicine · doi:10.1084/jem.53.2.151 · Cited by 14
THE CONCENTRATION OF ANTIPNEUMOCOCCUS SERUM
Felton, L. D. (1930) · JAMA · doi:10.1001/jama.1930.02710500011005 · Cited by 13
Meningococcus Toxin and Antitoxin III. Further Tests on Monkeys
Ferry, N. S. (1934) · The Journal of Immunology · Cited by 13
Felton, L. D. (1931) · The Journal of Immunology · doi:10.4049/jimmunol.21.5.341 · Cited by 13
THE INTRAVENOUS SERUM TREATMENT OF EPIDEMIC CEREBROSPINAL MENINGITIS
HERRICK, W. W. (1918) · Archives of Internal Medicine · doi:10.1001/archinte.1918.00090090121005 · Cited by 13
THE SPECIFIC SERUM TREATMENT OF PNEUMOCOCCUS TYPE II PNEUMONIA
Finland, M. (1933) · JAMA · doi:10.1001/jama.1933.02740080024006 · Cited by 13
Serological Diversity Among Meningococci
Branham, S. E. (1932) · The Journal of Immunology · doi:10.4049/jimmunol.23.1.49 · Cited by 13
STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION
ROBERTSON, O. H., & Sia, R. H. P. (1924) · The Journal of Experimental Medicine · doi:10.1084/jem.40.4.467 · Cited by 12
ANTIPNEUMOCOCCUS SERUM IN LOBAR PNEUMONIA
Park, W. H., & Cooper, G. N. (1928) · JAMA · doi:10.1001/jama.1928.02690440005002 · Cited by 12
Serums, Antitoxin, and Drugs in the Treatment of Meningococcus Meningitis
Branham, S. E. (1938) · Public Health Reports (1896-1970) · doi:10.2307/4582519 · Cited by 10
Meningococcus Toxin and Antitoxin IV. Further Tests on Guinea Pigs and Rabbits
Ferry, N. S., & Schornack, P. J. (1934) · The Journal of Immunology · Cited by 10
RELATION OF BACTEREMIA IN LOBAR PNEUMONIA TO PROGNOSIS AND THERAPY
ROSENBLÜTH, M. B. (1928) · JAMA · doi:10.1001/jama.1928.02690440007003 · Cited by 10
PNEUMOCOCCUS INFECTION AND LOBAR PNEUMONIA
Cole, R. (1914) · Archives of Internal Medicine · doi:10.1001/archinte.1914.00070130063005 · Cited by 10
STUDIES ON EXPERIMENTAL PNEUMONIA
Cecil, R. L., & Blake, F. G. (1920) · The Journal of Experimental Medicine · doi:10.1084/jem.32.1.1 · Cited by 10
STUDIES ON ANTIBLASTIC IMMUNITY
Blake, F. G. (1917) · The Journal of Experimental Medicine · doi:10.1084/jem.26.4.563 · Cited by 10
PARAMENINGOCOCCUS AND ITS ANTISERUM
Wollstein, M. (1914) · The Journal of Experimental Medicine · doi:10.1084/jem.20.3.201 · Cited by 10
Dochez, A. R. (1912) · The Journal of Experimental Medicine · doi:10.1084/jem.16.5.680 · Cited by 9
THE PRODUCTION AND TITRATION OF POTENT HORSE ANTIPNEUMOTOXIN
Parker, J. T., & McCoy, M. V. S. (1929) · The Journal of Experimental Medicine · doi:10.1084/jem.50.1.103 · Cited by 9
A METHOD OF SERUM TREATMENT OF PNEUMOCOCCIC SEPTICEMIA IN RABBITS
Bull, C. G. (1915) · The Journal of Experimental Medicine · doi:10.1084/jem.22.4.466 · Cited by 7
FATALITY RATES IN CEREBROSPINAL MENINGITIS
Walsh, G. (1938) · JAMA · doi:10.1001/jama.1938.02790230010005 · Cited by 7
THE STANDARDIZATION OF ANTIPNEUMOCOCCIC SERUM TYPES I AND II
Zozaya, J., Boyer, J., & Clark, J. (1930) · The Journal of Experimental Medicine · doi:10.1084/jem.52.4.471 · Cited by 7
DIRECT COMPARISON BETWEEN SPECIFIC AND NONSPECIFIC SERUM THERAPY FOR TYPE I LOBAR PNEUMONIA
Sutliff, W. D. (1933) · Archives of Internal Medicine · doi:10.1001/archinte.1933.00150220110008 · Cited by 6
Sabin, A. B. (1932) · The Journal of Experimental Medicine · doi:10.1084/jem.56.4.531 · Cited by 6
A STATISTICAL REVIEW OF 525 CASES OF LOBAR PNEUMONIA.
Maccordick, A. H. (1931) · PubMed · Cited by 6
THE THERAPEUTIC VALUE OF INTRAMUSCULAR DOSAGE OF TYPE I PNEUMOCOCCUS ANTISERA
Curphey, T. J., & Baruch, H. B. (1932) · The Journal of Experimental Medicine · doi:10.1084/jem.55.6.925 · Cited by 5
Mehlman, J., & Seegal, B. C. (1934) · The Journal of Immunology · doi:10.4049/jimmunol.27.1.81 · Cited by 4
Comparative Titrations of Antimeningococcus Sera Produced with Living Cells and with Broth Filtrates
Kirkbride, M. B., & Cohen, S. M. (1937) · The Journal of Immunology · doi:10.4049/jimmunol.33.5.375 · Cited by 4
THE SPECIFIC TREATMENT OF LOBAR PNEUMONIA
Belk, W. P. (1935) · JAMA · doi:10.1001/jama.1935.02760370024010 · Cited by 4
Sabin, A. B. (1933) · The Journal of Experimental Medicine · doi:10.1084/jem.57.1.139 · Cited by 4
Protection of Mice against Meningococcus Infection by Polyvalent Antimeningococcic Serum
Branham, S. E. (1935) · Public Health Reports (1896-1970) · doi:10.2307/4581558 · Cited by 4
Studies on Antibacterial Serums
Hitchens, A. P., & Hansen, G. (1916) · The Journal of Immunology · doi:10.4049/jimmunol.1.4.355 · Cited by 2
Currie, J. R., & Macgregor, A. S. M. (1908) · The Lancet · doi:10.1016/s0140-6736(00)78855-6 · Cited by 2
Nuclear medicine in district general hospitals.
Croft, D. (1979) · BMJ · doi:10.1136/bmj.2.6201.1336 · Cited by 2
Robb, A. G. (1908) · BMJ · doi:10.1136/bmj.1.2459.382-a · Cited by 2
The Curative Action of Anti-Pneumococcus Serum (Type I) in Mice
Petrie, G. F., & Morgan, W. T. J. (1932) · PubMed Central · Cited by 2
The Titration of Anti-pneumococcus Serum (Type 1) in Mice.
Morgan, W. T. J., & Petrie, G. F. (1933) · PubMed Central · Cited by 1
Cited by
Sorted by citations
Vaccines for preventing pneumococcal infection in adults
Moberley, S. A., Holden, J., Tatham, D. P., & Andrews, R. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub3 · Cited by 970
The convalescent sera option for containing COVID-19
Casadevall, A., & Pirofski, L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138003 · Cited by 904
Self-citationDeployment of convalescent plasma for the prevention and treatment of COVID-19
Bloch, E. M., Shoham, S., Casadevall, A., Sachais, B. S., Shaz, B. H., Winters, J. L., van Buskirk, C. M., Grossman, B. J., Joyner, M. J., Henderson, J. P., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138745 · Cited by 805
Self-citationAn Update on Current Therapeutic Drugs Treating COVID-19
Wu, R., Wang, L., Kuo, H. D., Shannar, A., Peter, R. M., Chou, P. J., Li, S. N., Hudlikar, R. R., Liu, X., Liu, Z., et al. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00216-7 · Cited by 600
Passive antibody therapy for infectious diseases
Casadevall, A., Dadachova, E., & Pirofski, L. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro974 · Cited by 542
Self-citation
Metadata
- Authors
- Casadevall, A., & Scharff, M. D.
- Affiliations
- Albert Einstein College of Medicine (US)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1994-08
- Volume
- 38
- Issue
- 8
- Pages
- 1695-1702
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC284624
- OpenAlex
- W2031152984
- Cited by
- 251
- References
- 84
- Citations by year
- 2025: 8 · 2024: 6 · 2023: 10 · 2022: 10 · 2021: 20 · 2020: 29 · 2019: 5 · 2018: 7 · 2017: 10 · 2016: 4 · 2015: 6 · 2014: 12 · 2013: 6 · 2012: 8
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-39839)
- National Institute of Allergy and Infectious Diseases (AI13342, AI33774, R01AI033774)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- serum therapy, animal models of infection, passive antibody therapy, passive immunization
- MeSH terms
- Animals, Disease Models, Animal, Humans, Immunization, Passive, Meningitis, Meningococcal, Pneumococcal Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review